J&J MedTech unveiled its long-awaited Ottava with FDA de novo authorization for the first table-integrated soft-tissue ...
The U.S. Food and Drug Administration (FDA) has granted De Novo authorization for Johnson & Johnson’s OTTAVA™ Robotic ...
While not disclosing a specific launch timeframe, with de novo clearance in hand, J&J initially plans to launch Ottava with ...
Johnson & Johnson (JNJ) wins FDA's De Novo authorization for the company’s soft tissue robotic system, Ottava. Read more here.
Johnson & Johnson has won U.S. Food and Drug Administration marketing authorization for its Ottava robotic surgical system. J&J on Wednesday said the FDA green light covers Ottava, the world's first ...
Johnson & Johnson (NYSE:JNJ) announced today that it received FDA de novo authorization for its Ottava surgical robot system.
Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the ...
While Johnson & Johnson will go head to head with Intuitive in the U.S., analysts questioned whether its robotic surgery ...
A multidisciplinary group of experts has issued recommendations for managing systemic cancer therapies in patients undergoing ...
A male in early adolescence presented with a 6-month history of a progressively enlarging upper abdominal mass.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results